Status:
RECRUITING
Feasibility Trial in Urban Pakistan for Community Engagement in Preventing Type II Diabetes and Risk Factors
Lead Sponsor:
Baqai Institute of Diabetology and Endocrinology
Collaborating Sponsors:
University of York
Khyber Medical University Peshawar
Conditions:
Type II Diabetes Mellitus
Eligibility:
All Genders
20+ years
Phase:
NA
Brief Summary
This project aims to adapt, implement, and evaluate PLA based intervention in urban Karachi, Pakistan for TIIDM prevention and control.
Detailed Description
The pivotal components of this approach include adapting, implementing, and evaluating the Participatory Learning and Action (PLA) based intervention for the prevention and control of Type II diabetes...
Eligibility Criteria
Inclusion
- Individuals aged 20 years and above.
- Participants residing in the randomized clusters of Karachi, Pakistan
- Individuals willing to participate in the study and provide consent.
- Both individuals with normoglycemia, intermediate hyperglycemia, and diabetes are encouraged to participate.
- Participants who can attend the scheduled meetings and interventions as per the study protocol.
Exclusion
- Individuals below the age of 20 years.
- Individuals unwilling to provide consent for participation.
- Participants with severe health conditions that may hinder their active involvement in the study.
- Individuals with non-compliance with research protocols
Key Trial Info
Start Date :
June 24 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2027
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT06570057
Start Date
June 24 2024
End Date
October 1 2027
Last Update
August 26 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Baqai Institute of Diabetology and Endocrinology (BIDE)
Karachi, Sindh, Pakistan, 74600